Literature DB >> 28507741

Mark Josephson and the ICD: A Personal Perspective.

Charles D Swerdlow1.   

Abstract

Mark Josephson dedicated his career to the prevention of premature sudden cardiac death (SCD). Toward that goal, he was an early adopter of the implantable cardioverter defibrillator (ICD) and indefatigable advocate for better ICD technology,[1] both as a clinical tool and as living laboratory to study SCD in ambulatory patients. With characteristic intellectual integrity and analytical rigour, he sought an honest and balanced appraisal of the life-saving benefits and serious complications of this unique therapy.

Entities:  

Year:  2017        PMID： 28507741      PMCID： PMC5430926          DOI： 10.15420/aer.2017.6.1:PP8

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  10 in total

Review 1.  All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.

Authors:  Jesús Almendral; Mark E Josephson
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

Review 2.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Authors:  Roderick Tung; Peter Zimetbaum; Mark E Josephson
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

3.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

Review 4.  The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.

Authors:  M E Josephson; D J Callans; A E Buxton
Journal:  Ann Intern Med       Date:  2000-12-05       Impact factor: 25.391

5.  Use of the automatic implantable cardioverter-defibrillator.

Authors:  W C Hargrove; J M Miller; M E Josephson
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

6.  Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms.

Authors:  K M Monahan; T Hadjis; N Hallett; D Casavant; M E Josephson
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

7.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

8.  Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

Authors:  Joseph J Germano; Matthew Reynolds; Vidal Essebag; Mark E Josephson
Journal:  Am J Cardiol       Date:  2006-03-09       Impact factor: 2.778

9.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.

Authors:  Lars Køber; Jens J Thune; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; Gunnar Jensen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper H Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson
Journal:  N Engl J Med       Date:  2016-08-27       Impact factor: 91.245

10.  The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.

Authors:  F E Marchlinski; B T Flores; A E Buxton; W C Hargrove; V P Addonizio; L W Stephenson; A H Harken; J U Doherty; E W Grogan; M E Josephson
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.